TMEM132A
Basic information
Region (hg38): 11:60924460-60937159
Previous symbols: [ "HSPA5BP1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TMEM132A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 66 | 69 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 66 | 5 | 2 |
Variants in TMEM132A
This is a list of pathogenic ClinVar variants found in the TMEM132A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-60924655-C-G | not specified | Uncertain significance (Jan 08, 2024) | ||
11-60924694-C-G | not specified | Uncertain significance (Dec 19, 2023) | ||
11-60927292-G-T | not specified | Uncertain significance (Mar 28, 2024) | ||
11-60927386-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
11-60927654-G-A | not specified | Uncertain significance (Aug 14, 2023) | ||
11-60927674-C-T | not specified | Uncertain significance (Oct 29, 2021) | ||
11-60927689-G-C | not specified | Uncertain significance (Dec 28, 2023) | ||
11-60927691-C-T | Benign (Mar 29, 2018) | |||
11-60927695-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
11-60927731-G-A | not specified | Uncertain significance (Dec 12, 2023) | ||
11-60927837-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
11-60927846-C-G | not specified | Uncertain significance (Nov 15, 2023) | ||
11-60927852-G-A | not specified | Uncertain significance (Jul 15, 2021) | ||
11-60928641-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
11-60928647-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
11-60928699-G-T | not specified | Uncertain significance (Mar 06, 2023) | ||
11-60928741-C-G | not specified | Uncertain significance (Aug 20, 2023) | ||
11-60928812-C-T | not specified | Uncertain significance (Jul 30, 2023) | ||
11-60928887-G-T | not specified | Uncertain significance (Feb 22, 2023) | ||
11-60928896-G-A | not specified | Uncertain significance (Sep 06, 2022) | ||
11-60928920-C-A | not specified | Uncertain significance (Jun 17, 2022) | ||
11-60928959-C-T | not specified | Uncertain significance (Jul 13, 2021) | ||
11-60930593-A-G | not specified | Uncertain significance (Jan 18, 2023) | ||
11-60930632-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
11-60931693-C-G | not specified | Uncertain significance (Feb 06, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TMEM132A | protein_coding | protein_coding | ENST00000005286 | 11 | 12697 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.04e-9 | 0.993 | 125653 | 0 | 95 | 125748 | 0.000378 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.796 | 590 | 647 | 0.912 | 0.0000427 | 6362 |
Missense in Polyphen | 214 | 231.37 | 0.92494 | 2333 | ||
Synonymous | 1.93 | 239 | 280 | 0.853 | 0.0000182 | 2351 |
Loss of Function | 2.50 | 20 | 36.3 | 0.552 | 0.00000179 | 369 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000757 | 0.000730 |
Ashkenazi Jewish | 0.000547 | 0.000397 |
East Asian | 0.000548 | 0.000544 |
Finnish | 0.000293 | 0.000277 |
European (Non-Finnish) | 0.000334 | 0.000308 |
Middle Eastern | 0.000548 | 0.000544 |
South Asian | 0.000681 | 0.000621 |
Other | 0.000356 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in embryonic and postnatal development of the brain. Increased resistance to cell death induced by serum starvation in cultured cells. Regulates cAMP-induced GFAP gene expression via STAT3 phosphorylation (By similarity). {ECO:0000250}.;
- Pathway
- Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
(Consensus)
Recessive Scores
- pRec
- 0.0995
Intolerance Scores
- loftool
- 0.779
- rvis_EVS
- -0.44
- rvis_percentile_EVS
- 24.71
Haploinsufficiency Scores
- pHI
- 0.203
- hipred
- N
- hipred_score
- 0.431
- ghis
- 0.646
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.516
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Tmem132a
- Phenotype
- embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; craniofacial phenotype;
Gene ontology
- Biological process
- biological_process;post-translational protein modification;cellular protein metabolic process
- Cellular component
- Golgi membrane;endoplasmic reticulum;endoplasmic reticulum lumen;endoplasmic reticulum membrane;Golgi apparatus;integral component of membrane;extracellular exosome
- Molecular function
- molecular_function